Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 4 | 2023 | 2118 | 0.740 |
Why?
|
| Cell Plasticity | 1 | 2021 | 24 | 0.740 |
Why?
|
| Clonal Evolution | 1 | 2020 | 27 | 0.700 |
Why?
|
| Spheroids, Cellular | 1 | 2020 | 57 | 0.690 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 344 | 0.600 |
Why?
|
| DNA Helicases | 3 | 2023 | 133 | 0.400 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 1316 | 0.370 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2021 | 167 | 0.360 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 617 | 0.220 |
Why?
|
| TCF Transcription Factors | 2 | 2020 | 20 | 0.220 |
Why?
|
| Cell Line, Tumor | 5 | 2022 | 2751 | 0.220 |
Why?
|
| Drug Discovery | 2 | 2022 | 124 | 0.210 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2023 | 67 | 0.210 |
Why?
|
| Carbon Monoxide | 2 | 2018 | 67 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 1893 | 0.180 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 183 | 0.170 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2022 | 197 | 0.170 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2019 | 23 | 0.170 |
Why?
|
| Histones | 1 | 2023 | 540 | 0.160 |
Why?
|
| Cytosol | 1 | 2018 | 209 | 0.150 |
Why?
|
| Logic | 1 | 2017 | 5 | 0.150 |
Why?
|
| Flavonols | 1 | 2017 | 11 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2018 | 102 | 0.140 |
Why?
|
| Down Syndrome | 1 | 2022 | 336 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 385 | 0.140 |
Why?
|
| Cell Survival | 1 | 2020 | 1024 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2020 | 757 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 331 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 178 | 0.130 |
Why?
|
| Adenocarcinoma | 1 | 2020 | 799 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2018 | 715 | 0.110 |
Why?
|
| Mitochondria | 1 | 2018 | 750 | 0.110 |
Why?
|
| Humans | 11 | 2023 | 115589 | 0.090 |
Why?
|
| Drug Design | 2 | 2022 | 156 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 180 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 2019 | 431 | 0.070 |
Why?
|
| Transcription, Genetic | 2 | 2020 | 1310 | 0.060 |
Why?
|
| Poly ADP Ribosylation | 1 | 2023 | 8 | 0.060 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2023 | 40 | 0.060 |
Why?
|
| Catalytic Domain | 1 | 2023 | 202 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 79 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 104 | 0.050 |
Why?
|
| Mice | 3 | 2023 | 15052 | 0.050 |
Why?
|
| Carcinogenesis | 1 | 2022 | 178 | 0.040 |
Why?
|
| RNA, Neoplasm | 1 | 2020 | 80 | 0.040 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 31 | 0.040 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2019 | 45 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 74 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 81 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2019 | 200 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 302 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2023 | 594 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 124 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 148 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 511 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 51 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 815 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 357 | 0.040 |
Why?
|
| Transcriptome | 1 | 2022 | 736 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1243 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 348 | 0.040 |
Why?
|
| Photochemical Processes | 1 | 2017 | 97 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 1048 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2017 | 447 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2022 | 1093 | 0.030 |
Why?
|
| Animals | 3 | 2023 | 32102 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1700 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 1147 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2022 | 3914 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 837 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2574 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 2377 | 0.020 |
Why?
|
| Female | 1 | 2020 | 59913 | 0.010 |
Why?
|